MEDS:NSD-Trxade Group Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 5.84

Change

0.00 (0.00)%

Market Cap

USD 8.10M

Volume

0.02M

Analyst Target

USD 11.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-18 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
WBA Walgreens Boots Alliance Inc

N/A

USD 13.83B
HITI High Tide Inc

N/A

USD 0.18B
PETS PetMed Express Inc

N/A

USD 0.09B
BIMI Bimi International Medical Inc

N/A

USD 0.01B
CJJD China Jo-Jo Drugstores Inc

N/A

USD 9.15M
LFLY Leafly Holdings Inc

N/A

USD 4.16M
LFLYW Leafly Holdings Inc

N/A

N/A
MDVLQ MedAvail Holdings Inc

N/A

N/A

ETFs Containing MEDS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.39% 75% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.39% 75% C 75% C
Trailing 12 Months  
Capital Gain 25.55% 75% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.55% 75% C 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -26.84% 50% F 13% F
Dividend Return -26.84% 50% F 13% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 88.75% 38% F 18% F
Risk Adjusted Return -30.25% 75% C 27% F
Market Capitalization 8.10M 43% F 9% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector